期刊文献+

胰岛素样生长因子结合蛋白-3在肝脏组织中的表达及意义(英文) 被引量:2

Immunohistochemical localization and clinical significance of insulin-like growth factor binding protein-3in liver tissues
下载PDF
导出
摘要 目的研究胰岛素样生长因子结合蛋白-3(Insulin-like growth factor binding protein-3,IGF-BP-3)在慢性肝炎、肝硬化及肝癌中的意义.方法收集11例正常肝组织、12例慢性肝炎、16例肝硬化及21例肝癌组织标本及临床资料.采用标记链霉素卵白素生物素(SABC)法,用抗IGFBP-3单克隆抗体(Sigma,14527)行免疫组织化学染色.结果正常对照、慢性肝炎、肝硬化及肝癌肝组织中IGFBP-3的表达阳性率分别为100.00%(11/11),100.00%(12/12),87.50%(14/16)及42.86%(9/21).采用Ridit分析,其IGFBP-3表达强度的R±SR值分别为0.7462±0.0288,0.6589±0.0413,0.5344±0.0610,0.2330±0.0373,R±1.96SR分别为0.6898~0.8026,0.6149~0.7767,0.4148~0.6540,0.159~0.3061.肝癌组织中IGFBP-3的表达强度明显低于肝硬化、慢性肝炎及正常对照肝组织(P<0.05);肝硬化肝组织明显低于正常肝组织(P<0.05);而在肝硬化与慢性肝炎肝组织之间,以及慢性肝炎肝组织与正常肝组织之间无显著区别(P>0.05).结论肝组织中IGFBP-3的表达强度可反映肝功能的损害程度.肝癌组织中IGFBP-3的表达强度显著降低. Objective: To investigate the expression of insulin-like growth factor binding protein-3(IGFBP-3)and its clinical significance in liver tissues with chronic hepatitis,liver cirrhosis,hepatocellular carcinoma(HCC)and healthy controls.Methods:60patients were recruited,including12cases of chronic hepatitis(mild,2;moder-ate,10),16cases of liver cirrhosis(Child A,9;Child B,4;Child C,3;respectively),21cases of HCC and11cases of healthy controls.Immunohistochemical staining for IGFBP-3was performed by SABC method.Results:The posi-tive immunostaining rate of IGFBP-3in liver tissues of healthy controls,chronic hepatitis,liver cirrhosis and HCC were100.00%(11/11),100.00%(12/12),87.50%(14/16)and42.86%(9/21),respectively.By Ridit test,the R±SR value of the immunostaining intensity of IGFBP-3were0.7462±0.0288,0.6958±0.0413,0.5344±0.0610,0.2330±0.0373,respectively;and the value of R±1.96SR were0.6898~0.8026,0.6149~0.7767,0.4148~0.6540,0.1599~0.3061,accordingly.The intensity of staining in HCC tissues was significantly lower than in the other three groups(P<0.05).A decreased expression of IGFBP-3in liver cirrhosis was found compared to normal controls(P<0.05).But there wasn't statistically significant difference between liver cirrhosis and chronic hepatitis(P>0.05)and between chronic hepatitis and normal controls(P>0.05).Conclusion:The expression intensity of IGFBP-3in liver tissues with cirrhosis and chronic hepatitis decreases and reflects the damage degree of liver function.The inhibition of apoptosis and enhanced proliferation of hepatocytes due to significantly reduced expression of IGFBP-3in HCC may be involved in hepatocarcinogenesis.
出处 《中国现代医学杂志》 CAS CSCD 2004年第22期29-32,37,共5页 China Journal of Modern Medicine
关键词 胰岛素样生长因子结合蛋白-3 慢性肝炎 肝硬化 肝癌 insulin-like growth factor binding protein-3 chronic hepatitis liver cirrhosis hepatocellular carci-noma
  • 相关文献

参考文献1

二级参考文献13

  • 1Moller S, Juul A, Becker U, et al. The acid-labile subunit of theternary insulin-like growth factor complex in cirrhosis: relation toliver dysfunction. J Hepatol, 2000, 32:441-446.
  • 2Assy N, Hochberg Z, Amit T, et al. Growth hormone-stimulatedinsulin-like growth factor (IGF)-Ⅰ and IGF-binding protein-3 inliver cirrhosis. J Hepatol, 1997, 27:796-802.
  • 3Donaghy A, Ross R, Gimson A, et al. Growth hormone, insulinlike growth factor- Ⅰ , and insulin-like growth factor binding 1 and3 in chronic liver disease. Hepatology, 1995, 21:680-688.
  • 4NikolicJA, Todorovic V, Bozic M, et al. Serum insulin-likegrowth factor ( IGF)- Ⅱ is more closely associated with liver dysfunction that is ( IGF)- Ⅰ in patients with cirrhosis. Clin ChimActa, 2000, 294: 169-177.
  • 5Caregaro L, Alberino F, Amodio P, et al. Nutritional and prognostic significance of insulin-like growth factor 1 in patients withliver cirrhosis. Nutrition, 1997, 13:185-190.
  • 6Petersen KF, Jacob R, West AB, et al. Effects of insulin-likegrowth factor Ⅰ on glucose metabolism in rats with liver cirrhosis.Am J Physiol, 1997, 273:e1189-e1193.
  • 7Inaba T, Saito H, Inoue T, et al. Growth hormone/insulin-likegrowth factor 1 axis alterations contribute to disturbed proteinmetabolism in cirrhosis patients after hepatectomy. J Hepatol,1999, 31:271-276.
  • 8Scharf JG, Schmitz F, Frystyk J, et al. Insulin-like growth factorI serum concentrations and patterns of insulin-like growth factorbinding proteins in patients with chronic liver disease. J Hepatol,1996, 25: 689-699.
  • 9Moller S, Juul A, Becker U, et al. Concentrations, release, anddisposal of insulin-like growth factor (IGF)-binding proteins,( IGFBP), IGF- Ⅰ , and growth hormone in different vascular bedsin patients with cirrhosis. J Clin Endocrinol Metab, 1995, 80:1146-1157.
  • 10Cuneo RC, Hickran PE, Wallace JD, et al. Altered endogenousgrowth hormone secretory kinetics and diurnal GH-binding proteinprofiles in adults with chronic liver disease. Clin Endocrinol, 1995,43:265-275.

共引文献15

同被引文献8

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部